ASHLEY MCGEE: Open Payments
NPI 1770165474 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 88 payments from 8 companies in 2025. Trend: 2023 $704 · 2024 $1,526 · 2025 $1,508
Food & beverage: $1,508
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $345 |
| Otsuka America Pharmaceutical, Inc. | 14 | $310 |
| ABBVIE INC. | 21 | $229 |
| Neurocrine BioSciences, Inc. | 13 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $159 |
| Alkermes, Inc. | 10 | $147 |
| Janssen Pharmaceuticals, Inc | 3 | $88 |
| Lundbeck LLC | 3 | $65 |
Products named: UZEDY, VRAYLAR, ABILIFY MAINTENA, REXULTI, INGREZZA, CAPLYTA, ARISTADA, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
